Confirmation of FZD5 implication in a cohort of 50 patients with ocular coloboma.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
01 2021
Historique:
received: 07 11 2019
accepted: 07 07 2020
revised: 01 07 2020
pubmed: 2 8 2020
medline: 17 8 2021
entrez: 2 8 2020
Statut: ppublish

Résumé

Defects in optic fissure closure can lead to congenital ocular coloboma. This ocular malformation, often associated with microphthalmia, is described in various clinical forms with different inheritance patterns and genetic heterogeneity. In recent times, the identification of an increased number of genes involved in numerous cellular functions has led to a better understanding in optic fissure closure mechanisms. Nevertheless, most of these genes are also involved in wider eye growth defects such as micro-anophthalmia, questioning the mechanisms controlling both extension and severity of optic fissure closure defects. However, some genes, such as FZD5, have only been so far identified in isolated coloboma. Thus, to estimate the frequency of implication of different ocular genes, we screened a cohort of 50 patients affected by ocular coloboma by using targeted sequencing of 119 genes involved in ocular development. This analysis revealed seven heterozygous (likely) pathogenic variants in RARB, MAB21L2, RBP4, TFAP2A, and FZD5. Surprisingly, three out of the seven variants detected herein were novel disease-causing variants in FZD5 identified in three unrelated families with dominant inheritance. Although molecular diagnosis rate remains relatively low in patients with ocular coloboma (14% (7/50) in this work), these results, however, highlight the importance of genetic screening, especially of FZD5, in such patients. Indeed, in our series, FZD5 variants represent half of the genetic causes, constituting 6% (3/50) of the patients who benefited from a molecular diagnosis. Our findings support the involvement of FZD5 in ocular coloboma and provide clues for screening this gene during current diagnostic procedures.

Identifiants

pubmed: 32737437
doi: 10.1038/s41431-020-0695-8
pii: 10.1038/s41431-020-0695-8
pmc: PMC7853074
doi:

Substances chimiques

Eye Proteins 0
FZD5 protein, human 0
Frizzled Receptors 0
Intracellular Signaling Peptides and Proteins 0
MAB21L2 protein, human 0
RBP4 protein, human 0
Receptors, Retinoic Acid 0
Retinol-Binding Proteins, Plasma 0
TFAP2A protein, human 0
Transcription Factor AP-2 0
retinoic acid receptor beta 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-140

Références

Patel A, Sowden JC. Genes and pathways in optic fissure closure. Semin Cell Dev Biol. 2019;91:55–65.
doi: 10.1016/j.semcdb.2017.10.010
Graw J. Eye development. Curr Top Dev Biol. 2010;90:343–86.
doi: 10.1016/S0070-2153(10)90010-0
Onwochei BC, Simon JW, Bateman JB, Couture KC, Mir E. Ocular colobomata. Sur Ophthalmol. 2000;45:175–94.
doi: 10.1016/S0039-6257(00)00151-X
Gestri G, Bazin-Lopez N, Scholes C, Wilson SW. Cell behaviors during closure of the choroid fissure in the developing eye. Front Cell Neurosci. 2018;12:42.
doi: 10.3389/fncel.2018.00042
Zagozewski JL, Zhang Q, Eisenstat DD. Genetic regulation of vertebrate eye development. Clin Genet. 2014;86:453–60.
doi: 10.1111/cge.12493
Plaisancie J, Ceroni F, Holt R, Zazo Seco C, Calvas P, Chassaing N, et al. Genetics of anophthalmia and microphthalmia. Part 1: non-syndromic anophthalmia/microphthalmia. Hum Genet. 2019;138:799–830.
doi: 10.1007/s00439-019-01977-y
AS AL, Gregory-Evans CY, Gregory-Evans K. An update on the genetics of ocular coloboma. Hum Genet. 2019;138:865–80.
doi: 10.1007/s00439-019-02019-3
Shah SP, Taylor AE, Sowden JC, Ragge NK, Russell-Eggitt I, Rahi JS, et al. Anophthalmos, microphthalmos, and typical coloboma in the United Kingdom: a prospective study of incidence and risk. Invest Ophthalmol Vis Sci. 2011;52:558–64.
doi: 10.1167/iovs.10-5263
Chassaing N, Causse A, Vigouroux A, Delahaye A, Alessandri JL, Boespflug-Tanguy O, et al. Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia. Clin Genet. 2014;86:326–34.
doi: 10.1111/cge.12275
Liu C, Widen SA, Williamson KA, Ratnapriya R, Gerth-Kahlert C, Rainger J, et al. A secreted WNT-ligand-binding domain of FZD5 generated by a frameshift mutation causes autosomal dominant coloboma. Hum Mol Genet. 2016;25:1382–91.
doi: 10.1093/hmg/ddw020
Rainger J, Williamson KA, Soares DC, Truch J, Kurian D, Gillessen-Kaesbach G, et al. A recurrent de novo mutation in ACTG1 causes isolated ocular coloboma. Hum Mutat. 2017;38:942–6.
doi: 10.1002/humu.23246
Fujimura N. WNT/beta-catenin signaling in vertebrate eye development. Front Cell Dev Biol. 2016;4:138.
doi: 10.3389/fcell.2016.00138
Liu C, Nathans J. An essential role for frizzled 5 in mammalian ocular development. Development. 2008;135:3567–76.
doi: 10.1242/dev.028076
Liu C, Bakeri H, Li T, Swaroop A. Regulation of retinal progenitor expansion by Frizzled receptors: implications for microphthalmia and retinal coloboma. Hum Mol Genet. 2012;21:1848–60.
doi: 10.1093/hmg/ddr616
Riviere JB, van Bon BW, Hoischen A, Kholmanskikh SS, O’Roak BJ, Gilissen C, et al. De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. Nat Genet. 2012;44:440–4.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
doi: 10.1038/gim.2015.30
Srour M, Chitayat D, Caron V, Chassaing N, Bitoun P, Patry L, et al. Recessive and dominant mutations in retinoic acid receptor beta in cases with microphthalmia and diaphragmatic hernia. Am J Hum Genet. 2013;93:765–72.
doi: 10.1016/j.ajhg.2013.08.014
Rainger J, Pehlivan D, Johansson S, Bengani H, Sanchez-Pulido L, Williamson KA, et al. Monoallelic and biallelic mutations in MAB21L2 cause a spectrum of major eye malformations. Am J Hum Genet. 2014;94:915–23.
doi: 10.1016/j.ajhg.2014.05.005
Kalaskar VK, Alur RP, Li LK, Thomas JW, Sergeev YV, Blain D, et al. High-throughput custom capture sequencing identifies novel mutations in coloboma-associated genes: mutation in DNA-binding domain of retinoic acid receptor beta affects nuclear localization causing ocular coloboma. Hum Mutat. 2019;41:678–95.
doi: 10.1002/humu.23954
Patel N, Khan AO, Alsahli S, Abdel-Salam G, Nowilaty SR, Mansour AM, et al. Genetic investigation of 93 families with microphthalmia or posterior microphthalmos. Clin Genet. 2018;93:1210–22.
doi: 10.1111/cge.13239
Robitaille JM, Zheng B, Wallace K, Beis MJ, Tatlidil C, Yang J, et al. The role of Frizzled-4 mutations in familial exudative vitreoretinopathy and Coats disease. Brit J Ophthalmol. 2011;95:574–9.
doi: 10.1136/bjo.2010.190116
Bang I, Kim HR, Beaven AH, Kim J, Ko SB, Lee GR, et al. Biophysical and functional characterization of Norrin signaling through Frizzled4. Proc Natl Acad Sci USA. 2018;115:8787–92.
doi: 10.1073/pnas.1805901115
Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, et al. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell. 2004;116:883–95.
doi: 10.1016/S0092-8674(04)00216-8

Auteurs

Marion Aubert-Mucca (M)

Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Toulouse, France.

Julie Pernin-Grandjean (J)

Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Toulouse, France.

Sébastien Marchasson (S)

Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Toulouse, France.

Veronique Gaston (V)

Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Toulouse, France.

Christophe Habib (C)

Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Toulouse, France.

Isabelle Meunier (I)

Centre de Référence des Maladies Sensorielles Génétiques, Hôpital Gui de Chauliac, Institut de Neurosciences de Montpellier, INSERM U1051, Université de Montpellier, Montpellier, France.

Sabine Sigaudy (S)

Département de Génétique Médicale, AP-HM, CHU Timone Enfants, Marseille, France.

Josseline Kaplan (J)

Laboratoire de Génétique Ophtalmologique, INSERM U1163 Institut Imagine, Paris, France.

Olivier Roche (O)

Département d'Ophtalmologie, IHU Necker-Enfants-Malades, Université Paris-Descartes, Paris, France.

Danièle Denis (D)

Institut de Neurosciences de la Timone (INT), Centre National de la Recherche Scientifique (CNRS), Aix-Marseille Université (AMU), Marseille, France.

Pierre Bitoun (P)

Département d'Ophtalmologie, SIDVA 91, Juvisy-sur-Orge, France.

Damien Haye (D)

Département de Génétique, Hôpital Robert Debré, Paris, France.

Alain Verloes (A)

Département de Génétique, Hôpital Robert Debré, Paris, France.

Patrick Calvas (P)

Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Toulouse, France.
INSERM U1056, UDEAR, Equipe 4, Université Toulouse III, Toulouse, France.
Centre de Référence des Affections Rares en Génétique Ophtalmologique CARGO, Site Constitutif, CHU Toulouse, Toulouse, France.

Nicolas Chassaing (N)

Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Toulouse, France.
INSERM U1056, UDEAR, Equipe 4, Université Toulouse III, Toulouse, France.
Centre de Référence des Affections Rares en Génétique Ophtalmologique CARGO, Site Constitutif, CHU Toulouse, Toulouse, France.

Julie Plaisancié (J)

Service de Génétique Médicale, Hôpital Purpan, CHU Toulouse, Toulouse, France. plaisancie.j@chu-toulouse.fr.
INSERM U1056, UDEAR, Equipe 4, Université Toulouse III, Toulouse, France. plaisancie.j@chu-toulouse.fr.
Centre de Référence des Affections Rares en Génétique Ophtalmologique CARGO, Site Constitutif, CHU Toulouse, Toulouse, France. plaisancie.j@chu-toulouse.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH